Clicky

Yuhan Corp Preferred(000105)

Description: Yuhan Corporation, a pharmaceutical company, engages in the research, development, and production of active pharmaceutical products and intermediates in South Korea and internationally. It offers antivirals, antibiotics, antihistamines, antidiabetics, beta-lactamase inhibitors, CNS intermediates, and PEGylated compounds; and Revanex, an acid pump antagonist for the treatment of peptic ulcers and gastritis-related mucosal injury. The company also provides ETC products, such as cardiovascular, alimentary, genito-urinary, metabolic, respiratory and allergy, and neuro systems, as well as anti-infective, anti-cancer, and hormone and other products; and analgesics, anti-rheumatics, and anesthetics. In addition, it offers over-the-counter (OTC) products, including vitamins and minerals, hepatopathy drugs and tonics, respiratory system drugs, alimentary system drugs, dermatology and analgesics drugs, and others; and household and healthcare products, such as bleaches, detergents, pesticides, and oral care products. Further, the company engages in dental business and provides implants, dental equipment/consumable, and dental care products. Additionally, the company manufactures and sells medical supplies for livestock, aquatic animals, and companion animals; and provides contract manufacturing services. Yuhan Corporation was founded in 1926 and is headquartered in Seoul, South Korea.


Keywords: Pharmaceutical Drugs Medication Antibiotics Healthcare Products Allergy Contract Manufacturing Services Oral Care Products Analgesic Over The Counter Drug Yuhan Active Pharmaceutical Products Dental Care Products Gastritis Related Mucosal Injury Medical Supplies Neuro Systems Peptic Ulcers Revanex

Home Page: www.yuhan.co.kr

74, Noryangjin-ro
Seoul,
South Korea
Phone: 82 2 828 0181


Officers

Name Title
Mr. Wook-Je Cho Pres, CEO & Exec. Director
Ms. Su Youn Nam M.D., Ph.D. Sr. MD & Director of Central Research Institute
Mr. Jong-Hong Lee Managing Director of Dental Bus. TFT
Mr. Chul-Ki Sa MD & Chief of Devel. Unit
Mr. Duk-Hyun Kang MD & GM of Living Health Department
Mr. Jung-Man Ha Managing Director
Mr. Hyeon-Yun Shin MD & GM of ETC Sales 5 Department
Mr. Bok-Kyu Yoon MD & GM of ETC Bus. 8 Department
Mr. Eun-Shik Kim Managing Director of Health Functional Food Bus. Tft
Mr. Jae-Kyo Kim Exec. Vice Director & Head of the Pharmaceutical Bus. Mgnt. Dept.

Exchange: KO

Country: KR

Currency: Korean Won (₩)

Forward PE: 30.303
Trailing PE: 0
Price-to-Book MRQ: 2.0174
Price-to-Sales TTM: 2.2213
IPO Date:
Fiscal Year End: December
Full Time Employees: 0
Back to stocks